The Manufacturing Execution System (MES) in the Life Sciences market in the United States is experiencing strong growth, driven by the increasing demand for digital transformation across pharmaceutical, biotechnology, and medical device manufacturing industries. U.S. companies are rapidly adopting MES solutions to enhance production efficiency, ensure regulatory compliance with strict FDA...